112 related articles for article (PubMed ID: 8661440)
1. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein.
García-Beato R; Martínez I; Francí C; Real FX; García-Barreno B; Melero JA
Virology; 1996 Jul; 221(2):301-9. PubMed ID: 8661440
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
Palomo C; Cane PA; Melero JA
J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
McGill A; Marsh R; Craft AW; Toms GL
J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
[TBL] [Abstract][Full Text] [Related]
4. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants.
Martínez I; Dopazo J; Melero JA
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2419-29. PubMed ID: 9349460
[TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
Marsh R; Connor A; Gias E; Toms GL
J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
[TBL] [Abstract][Full Text] [Related]
6. Detection of human respiratory syncytial virus genotype specific antibody responses in infants.
McGill A; Greensill J; Marsh R; Craft AW; Toms GL
J Med Virol; 2004 Nov; 74(3):492-8. PubMed ID: 15368511
[TBL] [Abstract][Full Text] [Related]
7. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein.
Martínez I; Melero JA
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2215-20. PubMed ID: 9747731
[TBL] [Abstract][Full Text] [Related]
8. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.
Sullender WM; Edwards KG
Virology; 1999 Nov; 264(1):230-6. PubMed ID: 10544149
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.
Hancock GE; Tebbey PW; Scheuer CA; Pryharski KS; Heers KM; LaPierre NA
J Med Virol; 2003 Jun; 70(2):301-8. PubMed ID: 12696122
[TBL] [Abstract][Full Text] [Related]
10. Antigenic analysis of chimeric and truncated G proteins of respiratory syncytial virus.
Sullender W
Virology; 1995 May; 209(1):70-9. PubMed ID: 7747486
[TBL] [Abstract][Full Text] [Related]
11. The use of monoclonal antibodies and lectins to identify changes in viral glycoproteins that are influenced by glycosylation: the case of human respiratory syncytial virus attachment (G) glycoprotein.
Rawling J; Melero JA
Methods Mol Biol; 2007; 379():109-25. PubMed ID: 17502674
[TBL] [Abstract][Full Text] [Related]
12. Mapping of monoclonal antibody epitopes of the human respiratory syncytial virus p protein.
García J; García-Barreno B; Martinez I; Melero JA
Virology; 1993 Jul; 195(1):239-42. PubMed ID: 7686311
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.
Sastre P; Melero JA; García-Barreno B; Palomo C
Vaccine; 2004 Dec; 23(4):435-43. PubMed ID: 15530691
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of human respiratory syncytial virus L protein.
Carromeu C; Simabuco FM; Tamura RE; Farinha Arcieri LE; Ventura AM
Arch Virol; 2007; 152(12):2259-63. PubMed ID: 17703289
[TBL] [Abstract][Full Text] [Related]
16. Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus.
Bastien N; Trudel M; Simard C
Virology; 1997 Jul; 234(1):118-22. PubMed ID: 9234952
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses.
Sullender WM; Britt WJ
J Gen Virol; 1996 Apr; 77 ( Pt 4)():641-8. PubMed ID: 8627252
[TBL] [Abstract][Full Text] [Related]
18. Genetic stability of the attachment glycoprotein of human respiratory syncytial viruses during serial passages in cell cultures.
de Sierra M; Arbiza J
Acta Virol; 2004; 48(2):115-21. PubMed ID: 15462287
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
Teng MN; Whitehead SS; Collins PL
Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection.
Cane PA; Thomas HM; Simpson AF; Evans JE; Hart CA; Pringle CR
J Med Virol; 1996 Mar; 48(3):253-61. PubMed ID: 8801286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
